Search research articles
Contact Us
Filters
Showing results (31-40 of 63) with videos related to
Page
of 7
Sort By:
JCO Oncology Advances
|
May 14, 2026
PEPN1924, A Phase II Study of Trastuzumab Deruxtecan in Patients With Recurrent Human Epidermal Growth Factor Receptor 2+ Osteosarcoma: A Children's Oncology Group Pediatric Early-Phase Clinical Trial Network Study
Damon R Reed, Katherine A Janeway, Charles G Minard, et al.
Translational Oncology
|
June 18, 2026
Combined inhibition of CDK4/6 and PI3K pathways exhibit highly synergistic activity and translational potential in Ewing sarcoma
Helen F Gloege, Maria Ana Isabel C De Los Santos, Advaita Chakraborty, et al.
JAMA Oncology
|
January 30, 2016
Multicenter Feasibility Study of Tumor Molecular Profiling to Inform Therapeutic Decisions in Advanced Pediatric Solid Tumors: The Individualized Cancer Therapy (iCat) Study
Marian H Harris, Steven G DuBois, Julia L Glade Bender, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 20, 2025
Molecular characterization informs prognosis in patients with localized Ewing sarcoma: A report from the Children's Oncology Group
Riaz Gillani, David S Shulman, Natalie J DelRocco, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 3, 2025
Molecular Characterization Informs Prognosis in Patients With Localized Ewing Sarcoma: A Report From the Children's Oncology Group
Riaz Gillani, David S Shulman, Natalie J DelRocco, et al.
British Journal of Cancer
|
March 19, 2019
Correction: Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group
David S Shulman, Kelly Klega, Alma Imamovic-Tuco, et al.
British Journal of Cancer
|
August 23, 2018
Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group
David S Shulman, Kelly Klega, Alma Imamovic-Tuco, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 14, 2019
High-throughput Chemical Screening Identifies Focal Adhesion Kinase and Aurora Kinase B Inhibition as a Synergistic Treatment Combination in Ewing Sarcoma
Sarah Wang, Elizabeth E Hwang, Rajarshi Guha, et al.
Cancer
|
July 30, 2019
Provocative questions in osteosarcoma basic and translational biology: A report from the Children's Oncology Group
Ryan D Roberts, Michael M Lizardo, Damon R Reed, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 26, 2026
A first-in-pediatric study of ALRN-6924, a novel stapled-peptide dual MDM2/MDMX inhibitor, for children with advanced hematologic and solid malignancies
David S Shulman, Kieuhoa T Vo, Frank M Balis, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 63) with videos related to
Sort By:
Page
of 7
JCO Oncology Advances
|
May 14, 2026
PEPN1924, A Phase II Study of Trastuzumab Deruxtecan in Patients With Recurrent Human Epidermal Growth Factor Receptor 2+ Osteosarcoma: A Children's Oncology Group Pediatric Early-Phase Clinical Trial Network Study
Damon R Reed, Katherine A Janeway, Charles G Minard, et al.
Translational Oncology
|
June 18, 2026
Combined inhibition of CDK4/6 and PI3K pathways exhibit highly synergistic activity and translational potential in Ewing sarcoma
Helen F Gloege, Maria Ana Isabel C De Los Santos, Advaita Chakraborty, et al.
JAMA Oncology
|
January 30, 2016
Multicenter Feasibility Study of Tumor Molecular Profiling to Inform Therapeutic Decisions in Advanced Pediatric Solid Tumors: The Individualized Cancer Therapy (iCat) Study
Marian H Harris, Steven G DuBois, Julia L Glade Bender, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 20, 2025
Molecular characterization informs prognosis in patients with localized Ewing sarcoma: A report from the Children's Oncology Group
Riaz Gillani, David S Shulman, Natalie J DelRocco, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 3, 2025
Molecular Characterization Informs Prognosis in Patients With Localized Ewing Sarcoma: A Report From the Children's Oncology Group
Riaz Gillani, David S Shulman, Natalie J DelRocco, et al.
British Journal of Cancer
|
March 19, 2019
Correction: Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group
David S Shulman, Kelly Klega, Alma Imamovic-Tuco, et al.
British Journal of Cancer
|
August 23, 2018
Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group
David S Shulman, Kelly Klega, Alma Imamovic-Tuco, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 14, 2019
High-throughput Chemical Screening Identifies Focal Adhesion Kinase and Aurora Kinase B Inhibition as a Synergistic Treatment Combination in Ewing Sarcoma
Sarah Wang, Elizabeth E Hwang, Rajarshi Guha, et al.
Cancer
|
July 30, 2019
Provocative questions in osteosarcoma basic and translational biology: A report from the Children's Oncology Group
Ryan D Roberts, Michael M Lizardo, Damon R Reed, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 26, 2026
A first-in-pediatric study of ALRN-6924, a novel stapled-peptide dual MDM2/MDMX inhibitor, for children with advanced hematologic and solid malignancies
David S Shulman, Kieuhoa T Vo, Frank M Balis, et al.
Page
of 7